Physiomics PLC (AIM:PYC), an oncology consultancy specialising in mathematical models for cancer treatment and personalised medicine, saw its share price jump by 10% following news of a key appointment to its senior management.
Dr Peter Sargent has been named as the firm's chief operating officer, effective immediately.
Before joining Physiomics, Sargent was with the international consultancy giant, Syneos Health Inc.
At 9.12 am, the shares were changing hands for 1.74p, up 0.16p.